Gene Patentability Reaffirmed, But Not Myriad Method Claims Genetic Engineering News A divided U.S. Court of Appeals for the Federal Circuit today delivered a mixed verdict to Myriad Genetics in its three-year legal wrangle to uphold seven patents for breast cancer susceptibility genes BRCA 1 and 2 and its method for analyzing those ... Court Rules Biotech Firm Can Patent Human Genes |
Thursday, August 16, 2012
Gene Patentability Reaffirmed, But Not Myriad Method Claims - Genetic Engineering News
torbjorntrainer1738.blogspot.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment